LINC01133 suppresses the EMT and metastasis of GC by acting as a ceRNA for miR-106a-3p to modulate APC expression and the Wnt/β-catenin pathway (Yang et al., 2018). This evidence concerns the gene LINC01133 and gastric cancer.